MEDICAL MARIJUANA, INC. News
More:  CANNABIS NEWS      SHOP     CONTACT
  • About Us
    • Company
    • We are a company of firsts
    • Marijuana Industry Overview
    • careers
  • Shop
    • CBD Products
    • Mood
    • Sleep
    • Skincare
  • News
    • Press Releases
    • Media Coverage
  • CBD Oil 101
    • CBD il: The Basics
    • Shop CBD Oil
    • CBD OIL FAQ´S
    • Is CBD Psychoactive?
    • CBD Serving: What is the Proper Serving Size?
    • CBD Vs THC – What Is The Difference?
    • VAPING 101
    • CBD Oil Recipes
  • Cannabis 101
    • What’s the Difference Between Hemp vs. Marijuana?
    • Where is Medical Marijuana Legal?
    • CBD Vs THC – What Is The Difference?
    • Marijuana Side Effects
    • How Long Does THC Stay in Your System?
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
Medical Marijuana, Inc. Featured in Forbes Story on the Rapidly Growing CBD Market

Medical Marijuana, Inc. Featured in Forbes Story on the Rapidly Growing CBD Market

by adminTorusBrand | Dec 13, 2016 | Axim Biotechnologies, Company News, Dixie Botanicals, Kannaway

[vc_row][vc_column][vc_column_text] Forbes profiles the success of Medical Marijuana, Inc. and our family of investment companies in recent article about CBD industry. On Monday, Forbes ran an article exploring the rapid expansion of the worldwide cannabidiol (CBD)...
Medical Marijuana, Inc. Proudly Supports Research into Difficult to Treat Medical Conditions

Medical Marijuana, Inc. Proudly Supports Research into Difficult to Treat Medical Conditions

by adminTorusBrand | Dec 9, 2016 | Axim Biotechnologies, Company News, Kannalife Sciences

[vc_row][vc_column][vc_column_text]Medical Marijuana, Inc. and our portfolio of investment companies are using cannabinoids to research potential new treatments for a range of medical conditions, including those that have proven notoriously hard to treat....
AXIM® Biotechnologies Receives Committee Approval to Begin IBS Studies

AXIM® Biotechnologies Receives Committee Approval to Begin IBS Studies

by adminTorusBrand | Dec 7, 2016 | Axim Biotechnologies, Company News

AXIM® Biotechnologies, a Medical Marijuana, Inc. investment company, is back in the news again this week, revealing that the company has gained the approval necessary to start next phase clinical trials for its CanChew® Plus cannabinoid-infused chewing gum. Following...
Medical Marijuana, Inc.’s Investment Company AXIM® Biotech Receives Approval From Medical Ethical Committee to Begin IBS Trial for CBD Product

Medical Marijuana, Inc.’s Investment Company AXIM® Biotech Receives Approval From Medical Ethical Committee to Begin IBS Trial for CBD Product

by adminTorusBrand | Dec 7, 2016 | Axim Biotechnologies, Press Releases

SAN DIEGO, CA –(Marketwired – December 06, 2016) – Medical Marijuana, Inc. (OTC PINK: MJNA), the world’s leading cannabis portfolio company and first-ever publicly traded cannabis company in the United States, announced today that its major...
AXIM® Biotechnologies Moves to Secure Rights to Proprietary Method for Extracting High-Purity THC

AXIM® Biotechnologies Moves to Secure Rights to Proprietary Method for Extracting High-Purity THC

by adminTorusBrand | Dec 7, 2016 | Axim Biotechnologies, Company News

Medical Marijuana, Inc. investment company AXIM® Biotechnologies has had a booming past couple of months, seeing its stock soar nearly 2000 percent year to date. Much of this growth has occurred because of the company’s tireless innovation in their mission to create...
AXIM® Biotechnologies Named to Top 5 Biotech Stocks of 2016

AXIM® Biotechnologies Named to Top 5 Biotech Stocks of 2016

by adminTorusBrand | Nov 30, 2016 | Axim Biotechnologies, Company News, Media Coverage

Despite troubles among most biotech companies this past year, some companies, like AXIM® Biotechnologies, were able to capitalize on market positioning, new innovations, and investor excitement to make major stock price gains. Medical Marijuana, Inc. investment...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company
  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets

Recent Comments

No comments to show.

SUBSCRIBE AND GET THE LATES NEWS

* indicates required

Follow us on

social networks

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Home     Company     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.